STOCK TITAN

Alkermes to Report First Quarter Financial Results on April 27, 2022

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Alkermes plc (Nasdaq: ALKS) will host a conference call on April 27, 2022, at 8:00 a.m. ET to discuss its first quarter financial results. The call will provide updates on the company's performance and future outlook. Investors can access the live webcast and slides through the Alkermes website. For participation, U.S. callers can dial +1 877 407 2988, while international callers can use +1 201 389 0923. A replay of the event will be available shortly after its conclusion.

Positive
  • None.
Negative
  • None.

DUBLIN, April 20, 2022 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET (1:00 p.m. BST) on Wednesday, April 27, 2022 to discuss the company's first quarter financial results. Management will also provide an update on the company.

The webcast player and accompanying slides may be accessed on the Investors section of Alkermes' website at www.alkermes.com. The conference call may be accessed by dialing +1 877 407 2988 for U.S. callers and +1 201 389 0923 for international callers. A replay of the webcast will be available approximately two hours after the completion of the event and may be accessed by visiting Alkermes' website. 

About Alkermes plc
Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

Alkermes Contact:
Alex Braun
Investor Relations
+1 781 296 8493

Alkermes plc Logo (PRNewsfoto/Alkermes plc)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/alkermes-to-report-first-quarter-financial-results-on-april-27-2022-301529145.html

SOURCE Alkermes plc

FAQ

When will Alkermes report its first quarter financial results for 2022?

Alkermes will report its first quarter financial results on April 27, 2022.

How can I access the Alkermes conference call?

You can access the conference call by dialing +1 877 407 2988 for U.S. callers or +1 201 389 0923 for international callers.

Where can I find the webcast for Alkermes' financial results?

The webcast and accompanying slides can be accessed on Alkermes' website in the Investors section.

What time will Alkermes' conference call take place?

The conference call will take place at 8:00 a.m. ET on April 27, 2022.

Will there be a replay of Alkermes' conference call?

Yes, a replay of the conference call will be available approximately two hours after the event.

Alkermes Inc. plc

NASDAQ:ALKS

ALKS Rankings

ALKS Latest News

ALKS Stock Data

4.77B
169.22M
1.33%
113.13%
9.78%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
DUBLIN 4